EU fines AstraZeneca on patents
EU fines AstraZeneca on patents
AstraZeneca was fined Euro 60 million by the European Union for blocking competition with its stomach ulcer medicine Losec, once the world's best selling drug. The antitrust authorities at the
Publication Date:
17/06/2005